Circadian Effects of Melatonin Receptor-Targeting Molecules In Vitro
Kaitlyn Chhe, Maya S Hegde, Stephanie R Taylor, Michelle E Farkas, Olga Cela, Rosella Scrima · 2024
Read Circadian Effects of Melatonin Receptor-Targeting Molecules In Vitro by Kaitlyn Chhe, Maya S Hegde, Stephanie R Taylor, Michelle E Farkas, Olga Cela, Rosella Scrima (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11727910.txt.
Description
A team of researchers tested melatonin-related drugs on body-clock cells in a dish in this 2024 paper. Daily rhythms govern sleep, thinking, and even DNA repair. Melatonin steers those rhythms by binding its MT1 receptor, which quiets the brain's master clock. Most earlier work used whole animals, leaving open what the drug does to clocks outside the brain.
The team used human bone-derived cells engineered to glow in rhythm, a living clock readout. They applied melatonin and a blocker that reverses MT1's usual action. The cells' rhythms shifted in response, showing their clocks answer to the receptor without any brain input. The setup lets drug hunters screen clock-shifting compounds cell by cell. It also matters for tissues everywhere that keep their own time.
Catalog record
| CREATOR | Kaitlyn Chhe, Maya S Hegde, Stephanie R Taylor, Michelle E Farkas, Olga Cela, Rosella Scrima |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |